Rocket Lab’s RKLB earnings story now centers on a $266 million U.S. Space Force contract, but the stock had already climbed about 88% over the past year before that award landed. Investors were paying up for launch demand that had been building since earlier defense and satellite bookings, not just the latest headline.
That share-price move outpaced the S&P 500’s 23% gain and topped defense peer LMT’s 39% rise, with Rocket Lab moving from $44.1 to $150.23 before settling at $82.83. For holders, the question is not whether demand exists; it is how much of the next leg is already embedded in the price.
Kratos, MACH-TB, and HASTE
Rocket Lab was selected by Kratos in February 2025 to support the next phase of the Department of Defense’s MACH-TB program, a $1.45 billion five-year effort to expand hypersonic technology testing. By May 2025, seven HASTE missions had been booked under MACH-TB, and both the U.S. and the United Kingdom had picked HASTE for hypersonic programs. That sequence mattered because it showed repeatable demand for the suborbital variant of Electron before the stock’s later run fully played out.
By May 2025, Rocket Lab was also on a multi-awardee U.S. Air Force contracting vehicle with a shared $46 billion ceiling, while iQPS had doubled its Electron order from four launches to eight. Rocket Lab flew the fifth iQPS launch just before the run began, then later added a third multi-launch Electron booking in late July 2026. The pattern was simple: more bookings, more visible backlog, and a defense pipeline that kept widening ahead of the price move.
$2.2 billion backlog, $200.3 million revenue
Rocket Lab reported $200.3 million in fiscal Q1 2026 revenue and roughly $2.2 billion in backlog, numbers that show how much work had already been pulled forward before July 2026. Backlog is not cash, but it does show scheduled demand sitting ahead of execution, and in this case it lined up with the earlier contract awards that had already been disclosed months before the market fully repriced the shares.
Implied volatility on Rocket Lab options sat in the 34th percentile of its trailing one-year range in June 2025, then in the 31st percentile five weeks later, even as the stock kept climbing. That mismatch matters for traders: the shares had already risen sharply while options pricing still suggested the market was positioned for a smaller move. The later $266 million U.S. Space Force award, the largest launch contract Rocket Lab has signed, added another layer to a story that was already visible in the order book.
What comes next for investors is not another background lesson on Rocket Lab’s business; it is whether the backlog and fresh launch bookings keep converting into revenue at the same pace as the contract announcements. The stock has already moved far ahead of where it started, and the remaining gap is how much of the next quarter’s revenue is still sitting in those awards rather than in the share price.
